Bi-mix (alprostadil recalls
The FDA has published 2 recalls involving Bi-mix (alprostadil since 2018. The latest was reported on 7 Nov 2018. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2018
Last 12 months0reported
Class I00% of total
Ongoing0latest 7 Nov 2018
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why bi-mix (alprostadil is recalled
Companies
By year
All bi-mix (alprostadil recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Bi-Mix Injection (Alprostadil 150 mcg/Lidocaine 2 mg/mL) recalled | Pharm D Solutions | Sterility | Nationwide |
| Drug | CLASS II | Bi-Mix Injection (Alprostadil 80 mcg/Lidocaine 2 mg/mL) recalled | Pharm D Solutions | Sterility | Nationwide |
Should you stop taking Bi-mix (alprostadil?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.